Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Heart

• Publication date

  2007-08-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/hrt.2008.150979PMID 18701534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

  2007cited by this paper
• Efficacy and safety of statin monotherapy in older adults: a meta-analysis.

  2007cited by this paper
• Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies

  2006cited by this paper
• Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

  2005cited by this paper
• Cardiovascular disease risk profiles.

  1991cited by this paper

• Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study

  2026cites this paper
• Retention of Omega-3 Fatty Acids (DHA and EPA) and Cooking Yield in Fish Cooked Using Wet-Heat Methods: Steaming vs. Bake-in-Foil

  2025cites this paper
• The Emerging Role of Cholesterol Absorption Inhibitors in Reducing Liver Cancer Risk

  2025cites this paper
• Efficacy and Safety of Hibiscus sabdariffa in Cardiometabolic Health: An Overview of Reviews and Updated Dose-Response Meta-Analysis.

  2025cites this paper
• Management of atherosclerotic cardiovascular disease risk in diabetes mellitus patients: a population-level observational cohort study in Wales

  2025cites this paper
• Intake of herring oil, but not of anchovy oil, resulted in a lower serum cholesterol concentration in male Zucker Diabetic Sprague Dawley rats

  2024cites this paper
• Refined selection of individuals for preventive cardiovascular disease treatment with a Transformer-based risk model

  2024influential citation
• Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis?

  2024cites this paper
• Apolipoprotein B - An ideal biomarker for atherosclerosis?

  2024cites this paper
• Towards artificial intelligence-based disease prediction algorithms that comprehensively leverage and continuously learn from real-world clinical tabular data systems

  2024cites this paper
• Cost-effectiveness of incentives for physical activity in coronary heart disease in Germany: pre-trial health economic model of a complex intervention following the new MRC framework

  2024cites this paper
• Development of predictive equation and score for 5-year metabolic syndrome incidence in Japanese adults

  2023cites this paper
• Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and Herzegovina

  2023cites this paper
• Identification and Management of Atherosclerotic Cardiovascular Disease Risk in South Asian Populations in the U.S.

  2023cites this paper
• Mulberry extract upregulates cholesterol efflux and inhibits p38 MAPK‐NLRP3‐mediated inflammation in foam cells

  2023cites this paper
• Metabolic Benefits of Phytosterols: Chemical, Nutritional, and Functional Aspects

  2023cites this paper
• High prevalence of cardiometabolic risk factors amongst young adults in the United Arab Emirates: the UAE Healthy Future Study

  2023cites this paper
• Lipid Panel Screening for Adults Living With Chronic Conditions

  2023cites this paper
• Effects of diets containing fish oils or fish oil concentrates with high cetoleic acid content on the circulating cholesterol concentration in rodents. A systematic review and meta-analysis

  2023cites this paper
• Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model

  2023cites this paper
• Change in cardiovascular health among adults with current or past major depressive disorder enrolled in intensive smoking cessation treatment.

  2023cites this paper
• Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease

  2023cites this paper
• Evidence supporting the choice of a new cardiovascular risk equation for Australia

  2023cites this paper
• Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial

  2022cites this paper
• Statin‐related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all‐cause mortality

  2022cites this paper
• Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease

  2022cites this paper
• Novel Pharmacological Approaches to the Treatment of Depression

  2022cites this paper
• Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice

  2022cites this paper
• Investigating the inflammatory status in the patients candidate for second angiography after coronary stent implantation

  2022cites this paper
• Stroke pathway — An evidence base for commissioning — An evidence review for NHS England and NHS Improvement

  2022cites this paper
• Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017

  2022cites this paper
• Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method

  2022cites this paper
• Distribution of lipid levels and prevalence of hyperlipidemia: data from the NHANES 2007–2018

  2022cites this paper
• Comparison of cardiac CT angiography coronary artery dimensions and ethnicity in Trinidad: the CADET pilot study

  2022cites this paper
• Oral fat tolerance testing identifies abnormal pancreatic β‐cell function and insulin resistance in individuals with normal glucose tolerance

  2022cites this paper
• Statin-use and perceptions of high cholesterol as predictors of healthy lifestyle behaviours in Nigerians

  2022cites this paper
• Effects of diets containing proteins from fish muscles or fish by-products on the circulating cholesterol concentration in rodents: a systematic review and meta-analysis

  2022cites this paper
• The Level of Remnant Cholesterol and Implications for Lipid-Lowering Strategy in Hospitalized Patients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China—Acute Coronary Syndrome Project

  2022cites this paper
• The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review

  2022cites this paper
• The source of the fat significantly affects the results of high-fat diet intervention

  2022cites this paper
• Cross-Sectional Study of Plant Sterols Intake as a Basis for Designing Appropriate Plant Sterol-Enriched Food in Indonesia

  2021cites this paper
• A scoping review of causal methods enabling predictions under hypothetical interventions

  2021cites this paper
• The nasocardiac reflex during nasoendoscopy: A commonly overlooked risk.

  2021cites this paper
• Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy

  2021cites this paper
• Pharmacogenetic association of diabetes-associated genetic risk score with rapid progression of coronary artery calcification following treatment with HMG-CoA-reductase inhibitors —results of the Heinz Nixdorf Recall Study

  2021cites this paper
• Factors affecting creatine phosphokinase elevation during daptomycin therapy using a combination of machine learning and conventional methods

  2021cites this paper
• Trends in cardiovascular disease risk factors by BMI category among adults in England, 2003‐2018

  2021cites this paper
• Taking sides with patients using institutional ethnography

  2021cites this paper
• Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence

  2021cites this paper
• Fish oil dietary supplements: a clinician’s point of view

  2021cites this paper
• Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK

  2021cites this paper
• Reduction of cardiovascular risk factors among young men with hypertension using an interactive decision aid: cluster-randomized control trial

  2021cites this paper
• In Utero Exposure to Persistent Organic Pollutants and Childhood Lipid Levels

  2021cites this paper
• Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults

  2021cites this paper
• Lipid screening and treatment after acute coronary syndrome – the chasm between guidelines and real-life practice in a tertiary care center in Sri Lanka

  2021cites this paper
• NHS Health Checks: an observational study of equity and outcomes 2009–2017

  2021cites this paper
• Cardiometabolic Health Risks, Lifestyle Behaviours and Quality of Life in People with Early Psychosis – A Cross Sectional Study

  2021cites this paper
• Egocentric social network characteristics and cardiovascular risk among patients with hypertension or diabetes in western Kenya: a cross-sectional analysis from the BIGPIC trial

  2021cites this paper
• Statins and Diabetes Risk

  2021cites this paper
• Higher Non-fasting Serum Triglyceride Preceding the Carotid Stenosis Progression

  2021cites this paper
• Uso de Estatinas Melhora a Proteção Cardiometabólica Promovida pelo Treinamento Físico em Ambiente Aquático: Um Ensaio Clínico Randomizado

  2021cites this paper
• Cost-effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care

  2021cites this paper
• Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registry

  2021cites this paper
• Analisi costo-efficacia di caplacizumab nel nuovo standard of care della porpora trombotica trombocitopenica immune in Italia

  2021cites this paper
• Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada

  2020cites this paper
• Management of Dyslipidaemia in the Elderly

  2020cites this paper
• EVALUATING THE SAFETY AND EFFICACY OF THE TRADITIONAL USE OF OLIVE LEAVES DECOCTION AS ANTIHYPERTENSIVE AGENT IN ELDERLY PEOPLE

  2020cites this paper
• Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.

  2020cites this paper
• Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults

  2020cites this paper
• Factors predicting statin prescribing for primary prevention: a historical cohort study

  2020cites this paper
• Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data

  2020cites this paper
• Impact of changes to national guidelines on hypertension-related workload: an interrupted time series analysis in English primary care

  2020cites this paper
• GPs’ familiarity with and use of cardiovascular clinical prediction rules: a UK survey study

  2020cites this paper
• A systematic review of causal methods enabling predictions under hypothetical interventions

  2020cites this paper
• Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review

  2020cites this paper
• Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

  2020cites this paper
• Dyslipidaemias and cardiovascular disease: Focus on the role of PCSK9 inhibitors Olga Panagiotopoulou.

  2020cites this paper
• An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England

  2020cites this paper
• An empirical analysis of dealing with patients who are lost to follow-up when developing prognostic models using a cohort design

  2020cites this paper
• A systematic review of population-based studies on lipid profiles in Latin America and the Caribbean

  2020cites this paper
• Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C

  2020cites this paper
• Polygenic Risk Scores for Genetic Counseling in Psychiatry: Lessons Learned from other Fields of Medicine.

  2020cites this paper
• Cardiovascular/stroke risk prevention: A new machine learning framework integrating carotid ultrasound image-based phenotypes and its harmonics with conventional risk factors

  2020cites this paper
• A 10-Year Risk of Cardiovascular Disease among Patients with Severe Mental Illness at Mbarara Regional Referral Hospital, Southwestern Uganda

  2020cites this paper
• Impact of sample size on the stability of risk scores from clinical prediction models: a case study in cardiovascular disease

  2020cites this paper
• The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented

  2020cites this paper
• A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients.

  2020cites this paper
• Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care

  2020cites this paper
• Effects of a lifestyle intervention on cardiovascular risk among high-risk individuals for diabetes in a low- and middle-income setting: Secondary analysis of the Kerala Diabetes Prevention Program.

  2020cites this paper
• Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register.

  2020cites this paper
• Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study.

  2020cites this paper
• Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Cardiovascular risk assessment in South and Middle-East Asians living in the Western countries

  2020cites this paper
• Saturated fats and the management of diabetes: the debates, controversies and consensus

  2020cites this paper
• Dietary and Blood Lipids in Cardiovascular Disease

  2020cites this paper
• Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan.

  2020cites this paper
• PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid

  2020cites this paper
• Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial

  2020cites this paper
• Impact of preventive screening and lifestyle interventions in women with a history of preeclampsia: A micro-simulation study

  2020cites this paper
• Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention

  2020cites this paper